Literature DB >> 28923133

Genetic evidence for a novel variant of the pilus island 1 backbone protein in group B Streptococcus.

Sarah Teatero1, Alefiya Neemuchwala1, Kunlin Yang1, Janice Gomes1, Taryn B T Athey1, Irene Martin2, Walter Demczuk2, Allison McGeer3,4, Nahuel Fittipaldi1,4.   

Abstract

PURPOSE: Pili contribute significantly to the pathogenesis of infection of group B Streptococcus (GBS) by facilitating adhesion and invasion of host cells. GBS pilin subunits (the backbone pilin protein, BP, and the ancillary pilin proteins, AP) as well as the specific enzymes required for pilus assembly are encoded by genes located in two separate genomic regions, known as pilus island 1 (PI-1) and PI-2. Our aim was to characterize the pilus profile of a collection of GBS isolates from metropolitan Toronto, Canada.
METHODOLOGY: The pilus profile of 1332 invasive and colonizing GBS isolates was determined by PCR and, in selected cases, by whole genome sequencing.
RESULTS: While investigating the pilus profile of a collection of GBS organisms, we discovered that 51 isolates possessed a novel variant of the PI-1 BP, which we named BP-1b. The predicted translated sequences of archetypical GBS BP-1 and novel BP-1b variants shared only 63 % amino acid sequence homology. The novel BP-1b variant was most common among strains of serotype Ib and VI, but was also found among strains of serotypes Ia, II, III and VIII.
CONCLUSION: We describe a relatively frequent occurrence of a novel PI-1 BP that cannot be detected by a commonly used multiplex PCR scheme, which could lead to strains being mistyped as PI-1 negative. We present PCR primers that can easily be incorporated into the multiplex PCR assay to identify strains with novel BP-1b variant.

Entities:  

Keywords:  GBS; PI-1; Streptococcus agalactiae; bacterial typing; group B Streptococcus; main pilin subunit; pilus; pilus subunit vaccines

Mesh:

Substances:

Year:  2017        PMID: 28923133     DOI: 10.1099/jmm.0.000588

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  3 in total

1.  Significant shifts in the distribution of vaccine capsular polysaccharide types and rates of antimicrobial resistance of perinatal group B streptococci within the last decade in St. Petersburg, Russia.

Authors:  Elena Shipitsyna; Kira Shalepo; Svetlana Zatsiorskaya; Anna Krysanova; Maria Razinkova; Alexey Grigoriev; Alevtina Savicheva
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-03-24       Impact factor: 3.267

2.  Identifying large-scale recombination and capsular switching events in Streptococcus agalactiae strains causing disease in adults in the UK between 2014 and 2015.

Authors:  Uzma Basit Khan; Elita Jauneikaite; Robert Andrews; Victoria J Chalker; Owen B Spiller
Journal:  Microb Genom       Date:  2022-03

3.  Genetic Diversity and Antimicrobial Drug Resistance of Serotype VI Group B Streptococcus, Canada.

Authors:  Alefiya Neemuchwala; Sarah Teatero; Lindsay Liang; Irene Martin; Walter Demzcuk; Allison McGeer; Nahuel Fittipaldi
Journal:  Emerg Infect Dis       Date:  2018-10       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.